STAT Plus: Foundation Medicine wins FDA approval for liquid biopsy able to detect mutations in multiple cancers
ADOBE
The FDA approved the second comprehensive “liquid biopsy” platform that can detect multiple kinds of cancer from tumor DNA circulating in a patient’s blood.
.png)
No hay comentarios:
Publicar un comentario